Terms & Conditions

IterOnco is a preclinical-stage biotechnology company developing therapies that reprogram the tumor microenvironment to improve treatment efficacy and reduce toxicity for patients with solid tumors.

Linkedin-in

Research

Tumor Microenvironment Remodeling
Next-Generation NK Cell Expansion Technology

Services

Our Science
Pipeline
Team & Ecosystem
Contact

Scientific, Preclinical & Regulatory Services

Visit Oncolexa.com

Newsletter

AI-generated translations

Terms & Conditions
Privacy Policy